We invite you to become a TOXINS 2024 supporter. Commercial support is an excellent way for your organization to show its commitment to advancing the field of botulinum and other neurotoxins.
The Exhibit Hall is an integral part of the TOXINS 2024 7th International Conference, offering exhibitors, both neurotoxin and non-neurotoxin–related, the opportunity to share with meeting attendees information on the most innovative and exciting advances in research and uses of neurotoxins.
Exhibitors interested in participating should review the Sponsor and Exhibitor Prospectus. Click the button below to download the PDF.
Please Note: On the applications below, be prepared to upload your company logo; this is a mandatory request.
Exhibitor Stand Packages
If you are looking for additional services that are not included the standard package, please contact Ivan Pimienta at email@example.com.
Ancillary Room Request
If your group is interested in securing meeting space during the TOXINS 2024 International Conference, please download and complete the Ancillary Room Application and email to firstname.lastname@example.org.
INA policy allows exhibiting companies and nonproﬁt organizations to host events during the TOXINS 2024 7th International Conference, but places limits on the times and venues of these events. Entertainment, meetings, or similar activities will not be permitted without prior International Neurotoxin Association approval.
The INA must review and approve ANY event affecting the TOXINS 2024 7th International Conference attendees and faculty during the inclusive dates of the conference before promotion and implementation of the event can occur, whether it is being held at INA-contracted facilities or otherwise.
Once your request has been approved by the INA, a coordinator from the Estrel Berlin will contact you for further details in order to confirm your request and provide a contract.
The sponsors must comply with the local authority’s regulations, EFPIA (European Federation of Pharmaceutical Industries and Associations [www.efpia.eu] and IFPMA (International Federation of Pharmaceutical Manufacturers & Associations [www.ifpma org]) Code of Practice on the Promotion of Medicines.